Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches

References

• Adams CL, Dimitrova I, Post MD, Gibson L, Spillman MA, Behbakht K, Bradford AP. 2019. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma. Exp Mol Pathol. 110:104284. doi:10.1016/j.yexmp.2019.104284.
   PubMed Web of Science ®Google Scholar
• Arita S, Kikkawa F, Kajiyama H, Shibata K, Kawai M, Mizuno K, Nagasaka T, Ino K, Nomura S. 2005. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma. Int J Gynecol Cancer. 15(2):329–336. doi:10.1136/ijgc-00009577-200503000-00024.
   PubMed Web of Science ®Google Scholar
• Banaganapalli B, Mansour H, Mohammed A, Alharthi AM, Aljuaid NM, Nasser KK, Ahmad A, Saadah OI, Al-Aama JY, Elango R, et al. 2020. Exploring celiac disease candidate pathways by global gene expression profiling and gene network cluster analysis. Sci Rep. 10(1):16290. doi:10.1038/s41598-020-73288-6.
   PubMed Web of Science ®Google Scholar
• Baranov VS, Osinovskaya NS, Yarmolinskaya MI. 2019. Pathogenomics of Uterine Fibroids Development. Int J Mol Sci. 20:24.
   Web of Science ®Google Scholar
• Barlin JN, Zhou QC, Leitao MM, Bisogna M, Olvera N, Shih KK, Jacobsen A, Schultz N, Tap WD, Hensley ML, et al. 2015. Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome. Neoplasia. 17(2):183–189.
   PubMed Web of Science ®Google Scholar
• Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K. 2003. Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters. Anticancer Res. 23(1B):729–732.
   PubMed Web of Science ®Google Scholar
• Böhm MJ, Marienfeld R, Jäger D, Mellert K, von Witzleben A, Brüderlein S, Wittau M, von Baer A, Schultheiss M, Mayer-Steinacker R, et al. 2019. Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib. Sarcoma. 2019:3914232. doi:10.1155/2019/3914232.
   PubMedGoogle Scholar
• Bondagji NS, Morad FA, Al-Nefaei AA, Khan IA, Elango R, Abdullah LS, M.Al-Mansouri N, Sabir J, Banaganapalli B, Edris S, et al. 2017. Replication of GWAS loci revealed the moderate effect of TNRC6B locus on susceptibility of Saudi women to develop uterine leiomyomas. J Obstet Gynaecol Res. 43(2):330–338. doi:10.1111/jog.13217
   PubMed Web of Science ®Google Scholar
• Carvalho-Silva D, Pierleoni A, Pignatelli M, Ong C, Fumis L, Karamanis N, Carmona M, Faulconbridge A, Hercules A, McAuley E, et al. 2019. Open Targets Platform: new developments and updates two years on. Nucleic Acids Res. 47(D1):D1056–D1065. doi:10.1093/nar/gky1133.
   PubMed Web of Science ®Google Scholar
• Chang HF, Cheng HT, Chen HY, Yeung WK, Cheng JY. 2019. Doxycycline inhibits electric field-induced migration of non-small cell lung cancer (NSCLC) cells. Sci Rep. 9(1):8094. doi:10.1038/s41598-019-44505-8.
   PubMedGoogle Scholar
• Chen B, Huang S, Pisanic TR, Stark A, Tao YS, Cheng B, Li Y, Wei Y, Zhao W, Wang T-H, et al. 2019. Rab8 GTPase regulates Klotho-mediated inhibition of cell growth and progression by directly modulating its surface expression in human non-small cell lung cancer. EBioMedicine. 49:118–132. doi:10.1016/j.ebiom.2019.10.040.
   PubMed Web of Science ®Google Scholar
• Chen I, Firth B, Hopkins L, Bougie O, Xie RH, Singh S. 2018. Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids. JSLS. 22(1):e2017.00066. doi:10.4293/JSLS.2017.00066.
   Web of Science ®Google Scholar
• Chen J, Bardes EE, Aronow BJ, Jegga AG. 2009. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37( Web Server issue):W305–311. doi:10.1093/nar/gkp427.
   PubMed Web of Science ®Google Scholar
• Cuppens T, Moisse M, Depreeuw J, Annibali D, Colas E, Gil-Moreno A, Huvila J, Carpen O, Zikan M, Matias-Guiu X, et al. 2018. Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways. Int J Cancer. 142(6):1230–1243. doi:10.1002/ijc.31129.
   PubMed Web of Science ®Google Scholar
• ElSokary HA, Abdullah LS, Ujaimi A, Sahly NN, Mansouri N, Banaganapalli B, Shaik NA, Elango R, Bondagji N. 2020. Assessing the role of serum prolactin levels and coding region somatic mutations of the prolactin gene in Saudi uterine leiomyoma patients. Arch Med Scie. doi:10.5114/aoms.2020.98658
   Google Scholar
• Elvin JA, Gay LM, Ort R, Shuluk J, Long J, Shelley L, Lee R, Chalmers ZR, Frampton GM, Ali SM, et al. 2017. Clinical benefit in response to palbociclib treatment in refractory uterine leiomyosarcomas with a common CDKN2A alteration. Oncologist. 22(4):416–421. doi:10.1634/theoncologist.2016-0310.
   PubMed Web of Science ®Google Scholar
• Gautier L, Cope L, Bolstad BM, Irizarry RA. 2004. affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 20(3):307–315. doi:10.1093/bioinformatics/btg405.
   PubMed Web of Science ®Google Scholar
• Green GH, Diggle PJ. 2007. On the operational characteristics of the Benjamini and Hochberg False Discovery Rate procedure. Stat Appl Genet Mol Biol. 6:Article27. doi:10.2202/1544-6115.1302.
   PubMed Web of Science ®Google Scholar
• Hamilton TB, Barilla KC, Romaniuk PJ. 1995. High affinity binding sites for the Wilms’ tumour suppressor protein WT1. Nucleic Acids Res. 23(2):277–284. doi:10.1093/nar/23.2.277.
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 4(2):249–264. doi:10.1093/biostatistics/4.2.249.
   PubMed Web of Science ®Google Scholar
• Koschutzki D, Schreiber F. 2008. Centrality analysis methods for biological networks and their application to gene regulatory networks. Gene Regul Syst Bio. 2:193–201. doi:10.4137/grsb.s702.
   PubMedGoogle Scholar
• Leiser AL, Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi DS, Soslow RA. 2006. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecol Oncol. 101(1):86–91. doi:10.1016/j.ygyno.2005.09.055.
   PubMed Web of Science ®Google Scholar
• Lv J, Zhu Y, Ji A, Zhang Q, Liao G. 2020. Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer. Biosci Rep. 40(4). doi:10.1042/BSR20194337.
   Web of Science ®Google Scholar
• Malik M, Norian J, McCarthy-Keith D, Britten J, Catherino WH. 2010. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin Reprod Med. 28(3):169–179. doi:10.1055/s-0030-1251475.
   PubMed Web of Science ®Google Scholar
• Mas A, Simon C. 2018. Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas. Biol Reprod. doi:10.1093/biolre/ioy097
   PubMed Web of Science ®Google Scholar
• Masoudi-Nejad A, Wang E. 2015. Cancer modeling and network biology: accelerating toward personalized medicine. Semin Cancer Biol. 30:1–3. doi:10.1016/j.semcancer.2014.06.005.
   PubMed Web of Science ®Google Scholar
• McClatchey AI, Yap AS. 2012. Contact inhibition (of proliferation) redux. Curr Opin Cell Biol. 24(5):685–694. doi:10.1016/j.ceb.2012.06.009.
   PubMed Web of Science ®Google Scholar
• McDermott JE, Taylor RC, Yoon H, Heffron F. 2009. Bottlenecks and hubs in inferred networks are important for virulence in Salmonella typhimurium. J Comput Biol. 16(2):169–180. doi:10.1089/cmb.2008.04TT.
   PubMed Web of Science ®Google Scholar
• Mendonsa AM, Na TY, Gumbiner BM. 2018. E-cadherin in contact inhibition and cancer. Oncogene. 37(35):4769–4780. doi:10.1038/s41388-018-0304-2.
   PubMed Web of Science ®Google Scholar
• Moroni R, Vieira C, Ferriani R, Dos Reis R, Nogueira A, Brito L. 2015. Presentation and treatment of uterine leiomyoma in adolescence: a systematic review. BMC Womens Health. 15(1):4. doi:10.1186/s12905-015-0162-9.
   PubMedGoogle Scholar
• Nallanthighal S, Heiserman JP, Cheon DJ. 2019. The role of the extracellular matrix in cancer stemness. Front Cell Dev Biol. 7:86. doi:10.3389/fcell.2019.00086.
   PubMed Web of Science ®Google Scholar
• Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, Floratos A, Sham PC, Li MJ, Wang J, et al. 2015. The support of human genetic evidence for approved drug indications. Nat Genet. 47(8):856–860. doi:10.1038/ng.3314.
   PubMed Web of Science ®Google Scholar
• Owen C, Armstrong AY. 2015. Clinical management of leiomyoma. Obstet Gynecol Clin North Am. 42(1):67–85. doi:10.1016/j.ogc.2014.09.009.
   PubMed Web of Science ®Google Scholar
• Pavel M, Renna M, Park SJ, Menzies FM, Ricketts T, Fullgrabe J, Ashkenazi A, Frake RA, Lombarte AC, Bento CF, et al. 2018. Contact inhibition controls cell survival and proliferation via YAP/TAZ-autophagy axis. Nat Commun. 9(1):2961. doi:10.1038/s41467-018-05388-x.
   PubMed Web of Science ®Google Scholar
• Rakshit H, Rathi N, Roy D. 2014. Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson’s disease. PLoS One. 9(8):e103047. doi:10.1371/journal.pone.0103047.
   PubMed Web of Science ®Google Scholar
• Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C. 2013. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology. 266(3):717–740. doi:10.1148/radiol.12120315.
   PubMed Web of Science ®Google Scholar
• Sanci M, Dikis C, Inan S, Turkoz E, Dicle N, Ispahi C. 2011. Immunolocalization of VEGF, VEGF receptors, EGF-R and Ki-67 in leiomyoma, cellular leiomyoma and leiomyosarcoma. Acta Histochem. 113(3):317–325. doi:10.1016/j.acthis.2010.01.001.
   PubMed Web of Science ®Google Scholar
• Santos P, Cunha TM. 2015. Uterine sarcomas: clinical presentation and MRI features. Diagn Interv Radiol. 21(1):4–9. doi:10.5152/dir.2014.14053.
   PubMed Web of Science ®Google Scholar
• Seluanov A, Hine C, Azpurua J, Feigenson M, Bozzella M, Mao Z, Catania KC, Gorbunova V. 2009. Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proc Natl Acad Sci U S A. 106(46):19352–19357. doi:10.1073/pnas.0905252106.
   PubMed Web of Science ®Google Scholar
• Selvaraj G, Kaliamurthi S, Kaushik AC, Khan A, Wei YK, Cho WC, Gu K, Wei DQ. 2018. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms. J Biomed Inform. 86:120–134. doi:10.1016/j.jbi.2018.09.004.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11):2498–2504. doi:10.1101/gr.1239303.
   PubMed Web of Science ®Google Scholar
• Shen Q, Chen M, Wang Y, Zhou Q, Tao X, Zhang W, Zhu X. 2015. Effects of laparoscopic versus minilaparotomic myomectomy on uterine leiomyoma: a meta-analysis. J Minim Invasive Gynecol. 22(2):177–184. doi:10.1016/j.jmig.2014.09.007.
   PubMed Web of Science ®Google Scholar
• Szklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., Santos, A., Doncheva, N. T., Roth, A., Bork, P., Jensen, L. J., & von Mering, C. (2017). The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic acids research, 45(D1), D362–D368. https://doi.org/10.1093/nar/gkw937
   Google Scholar
• Tomczak K, Czerwinska P, Wiznerowicz M. 2015. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 19(1A):A68–77. doi:10.5114/wo.2014.47136.
   PubMedGoogle Scholar
• Tsuyoshi H, Yoshida Y. 2018. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma. Cancer Sci. 109(6):1743–1752. doi:10.1111/cas.13613.
   PubMed Web of Science ®Google Scholar
• West J, Newton PK. 2019. Cellular interactions constrain tumor growth. Proc Natl Acad Sci U S A. 116(6):1918–1923. doi:10.1073/pnas.1804150116.
   PubMed Web of Science ®Google Scholar
• Yang Q, Nair S, Laknaur A, Ismail N, Diamond MP, Al-Hendy A. 2016. The polycomb group protein EZH2 impairs DNA damage repair gene expression in human uterine fibroids. Biol Reprod. 94(3):69. doi:10.1095/biolreprod.115.134924.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Chang L, Jin H, Guang L. 2020. Biological omics analysis of tumor mutation burden combined with immune inltrates in uterine corpus endometrial carcinoma. Res Square-preprint. doi:10.21203/rs.3.rs-37252/v1.
   Google Scholar
• Zhang W, Cheng Z, Qu X, Dai H, Ke X, Chen Z. 2014. Overexpression of myosin is associated with the development of uterine myoma. J Obstet Gynaecol Res. 40(9):2051–2057. doi:10.1111/jog.12461.
   PubMed Web of Science ®Google Scholar